SNHG12 and prostate carcinoma: SNHG12 is dysregulated in multiple kinds of human cancers, including prostate cancer [22], gastric cancer [31], cervical cancer [34], hepatocellular carcinoma (HCC) [33], renal cell carcinoma [28], nasopharyngeal carcinoma [50], glioma [35], breast cancer [36], non-small cell lung cancer [29], ovarian cancer [24], colorectal cancer [51], and osteosarcoma [30].